scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JTCVS.2006.05.070 |
P698 | PubMed publication ID | 17198774 |
P50 | author | Louis-Mathieu Stevens | Q40276972 |
P2093 | author name string | Louis P Perrault | |
Ismail El-Hamamsy | |||
Denis Bouchard | |||
Michel Carrier | |||
Michel Pellerin | |||
Raymond Cartier | |||
Pierre Page | |||
Philippe Demers | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | coronary artery bypass surgery | Q186020 |
placebo | Q269829 | ||
acetylcysteine | Q375613 | ||
P304 | page(s) | 7-12 | |
P577 | publication date | 2007-01-01 | |
P1433 | published in | The Journal of Thoracic and Cardiovascular Surgery | Q2795598 |
P1476 | title | Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial | |
P478 | volume | 133 |
Q92713303 | A phase 2 trial of N-Acetylcysteine in Biliary atresia after Kasai portoenterostomy |
Q87531036 | Addition of N-acetyl cysteine to carvedilol decreases the incidence of acute renal injury after cardiac surgery |
Q27012839 | Antioxidant supplementations for prevention of atrial fibrillation after cardiac surgery: an updated comprehensive systematic review and meta-analysis of 23 randomized controlled trials |
Q38202561 | Antioxidants for prevention of atrial fibrillation: a potentially useful future therapeutic approach? A review of the literature and meta-analysis |
Q26781711 | Attenuating the Systemic Inflammatory Response to Adult Cardiopulmonary Bypass: A Critical Review of the Evidence Base |
Q37821171 | Beyond the guidelines: new and novel agents for the prevention of atrial fibrillation after cardiothoracic surgery |
Q65001489 | Can acetylcysteine ameliorate cisplatin-induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double-blind, placebo-controlled trial involving patients with head and neck cancer. |
Q55449214 | Cardiac and Vascular Surgery-Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group. |
Q38582827 | Cardiovascular effects of hyperoxia during and after cardiac surgery. |
Q26770909 | Compromised redox homeostasis, altered nitroso-redox balance, and therapeutic possibilities in atrial fibrillation |
Q37767080 | Does the prophylactic administration of N-acetylcysteine prevent acute kidney injury following cardiac surgery? |
Q46962300 | Effect of N-acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: a randomized controlled trial |
Q35774842 | Effectiveness of intravenous infusion of N-acetylcysteine in cirrhotic patients undergoing major abdominal surgeries |
Q90469858 | Effects of N-acetyl cysteine and melatonin on early reperfusion injury in patients undergoing coronary artery bypass grafting: A randomized, open-labeled, placebo-controlled trial |
Q33576134 | Efficacy of N-acetylcysteine in preventing atrial fibrillation after cardiac surgery: a meta-analysis of published randomized controlled trials |
Q37285952 | Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: a systematic review of randomized trials. |
Q37061151 | Imaging ROS signaling in cells and animals |
Q39572164 | Impact of N-acetylcysteine on neonatal cardiomyocyte ischemia-reperfusion injury |
Q38175522 | Inflammation in new-onset atrial fibrillation after cardiac surgery: a systematic review. |
Q36070565 | Mesenchymal stromal cells in renal ischemia/reperfusion injury. |
Q46064875 | Modification of epinephrine-induced arrhythmias by N-acetyl-L-cysteine and vitamin E. |
Q34171904 | N-Acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials |
Q98386218 | N-acetylcysteine alleviates post-resuscitation myocardial dysfunction and improves survival outcomes via partly inhibiting NLRP3 inflammasome induced-pyroptosis |
Q24200340 | N-acetylcysteine for sepsis and systemic inflammatory response in adults |
Q37828323 | N-acetylcysteine for the prevention of acute kidney injury after cardiac surgery |
Q43241198 | N-acetylcysteine improves early cardiac isograft function in a rat heterotopic transplantation model |
Q64060821 | N-acetylcysteine use among patients undergoing cardiac surgery: A systematic review and meta-analysis of randomized trials |
Q37887771 | Nitric oxide: a guardian for vascular grafts? |
Q46058228 | Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection |
Q37029127 | Oxidative damage in clinical ischemia/reperfusion injury: a reappraisal |
Q87193908 | Oxidative status, inflammation, and postoperative atrial fibrillation with metoprolol vs carvedilol or carvedilol plus N-acetyl cysteine treatment |
Q46528208 | Oxidative stress and antioxidative defense parameters early after reperfusion therapy for acute myocardial infarction |
Q37852637 | Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. |
Q42743919 | Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats. |
Q44729928 | Prophylactic high-dose oral-N-acetylcysteine does not prevent atrial fibrillation after heart surgery: a prospective double blind placebo-controlled randomized clinical trial |
Q93609063 | References |
Q92415386 | Safety and efficacy of adding intravenous N-acetylcysteine to parenteral L-alanyl-L-glutamine in hospitalized patients undergoing surgery of the colon: a randomized controlled trial |
Q87393334 | Section 3: Prevention and Treatment of AKI |
Q87393341 | Section 4: Contrast-induced AKI |
Q37358300 | The Protective Role of Resveratrol against Arsenic Trioxide-Induced Cardiotoxicity |
Q33484058 | What was hot and what was not in 2007?: a literature review |
Search more.